Jason

Lifetime Cannabis Use Not Tied To Dementia In Surprising New Study

A recent study conducted by investigators at Yale University and the University of Oxford in the United Kingdom analyzed cognitive…

5 months ago

The Cannabis Industry Forgot Who Built It

Legal cannabis promised legitimacy. Instead, many of the people who carried the culture through prohibition are being priced, regulated, and…

5 months ago

Why Does Watching The World Cup Feel Like A Panic Attack? Weed Can Help, If You Don’t Screw It Up.

The World Cup can trigger intense stress responses that closely resemble the body’s reaction to real threats, making anxiety management…

5 months ago

A U.S. Weed Company Finally Cracked The NYSE. It Had To Leave The Recreational Pot Behind.

Trulieve becomes the first U.S. cannabis company to trade on the NYSE on June 10. To get through the door,…

5 months ago

AI Is Growing Your Weed Now

From robot canopy scanners to algorithmic breeders to AI-powered dispensary counters, artificial intelligence is remaking cannabis at every level. The…

5 months ago

The THC Breathalyzer Hype Machine: Why This Technology Still Doesn’t Solve the Problem

The latest version of this story comes from Virginia Commonwealth University, where researcher Emanuele Alves developed a portable, 3D-printed device…

5 months ago

From Ditch Weed to Dank: The Lost World of 1977 Cannabis and Why It Still Matters

But there's more to this image than nostalgia and comedy. What you're looking at in that High Times spread is…

5 months ago

The WNBA Just Dropped Its Weed Ban. It Banned Psychedelics In The Same Breath.

The league pulled marijuana off its banned list in the new players’ agreement. In the same document, it banned psilocybin,…

5 months ago

Medical Cannabis Behind the Wheel: NSW Proposes ‘Three Strikes’ Before Penalties

In New South Wales, Australia, patients can legally use medical cannabis with a prescription. So far, so good. But the…

5 months ago

Wall Street Is About to Steal Psychedelics From the People Who Need Them

The clinical evidence is real. The valuations are not. Compass Pathways: $560 million market cap, zero revenue. MindMed: up to…

5 months ago